Inactivation and inhibition of gamma-aminobutyric acid aminotransferase by conformationally restricted vigabatrin analogues.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2002-08-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM020134IPMID 12238932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase.

  2002cited by this paper
• The inhibitory neural circuitry as target of antiepileptic drugs.

  2001cited by this paper
• Isolation and characterization of the product of inactivation of gamma-aminobutyric acid aminotransferase by gabaculine.

  1999cited by this paper
• Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy.

  1999cited by this paper
• Syntheses of (Z)-and (E)-4-amino-2-(trifluoromethyl)-2-butenoic acid and their inactivation of gamma-aminobutyric acid aminotransferase.

  1999cited by this paper
• The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats.

  1999cited by this paper
• Inhibition and substrate activity of conformationally rigid vigabatrin analogues with gamma-aminobutyric acid aminotransferase.

  1999cited by this paper
• A novel strategy for the treatment of cocaine addiction

  1998cited by this paper
• A fast flexible docking method using an incremental construction algorithm.

  1996cited by this paper
• Active site model for γ‐aminobutyrate aminotransferase explains substrate specificity and inhibitor reactivities

  1995cited by this paper
• Mechanism-based enzyme inactivators.

  1995cited by this paper
• Mechanisms of action of antiepileptic drugs.

  1995cited by this paper
• Chemistry of the inactivation of 4-aminobutyrate aminotransferase by the antiepileptic drug vigabatrin.

  1991cited by this paper
• Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease.

  1990cited by this paper
• GABA in Epilepsy: The Pharmacologic Basis

  1989cited by this paper
• On the role of GABA as an inhibitory neurotransmitter in inferior colliculus neurons: iontophoretic studies.

  1989cited by this paper
• Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators.

  1989cited by this paper
• Stoichiometry and stability of the adduct formed between human 4-aminobutyrate aminotransferase and 4-aminohex-5-enoate: sequence of a labelled peptide.

  1989cited by this paper
• L-Glutamate-L-amino acid transaminases.

  1985cited by this paper
• Glutamate-gamma-aminobutyrate transaminase.

  1985cited by this paper
• A centrifuged-column procedure for the measurement of ligand binding by beef heart F1.

  1979cited by this paper
• 4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain.

  1977cited by this paper
• Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.

  1973cited by this paper
• Conformation and reaction specificity in pyridoxal phosphate enzymes.

  1966cited by this paper
• Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

  1962cited by this paper
• The determination of enzyme inhibitor constants.

  1953cited by this paper

• Research Status, Synthesis and Clinical Application of antiepileptic drugs.

  2023cites this paper
• Bioactive substances inhibiting COX-2 and cancer cells isolated from the fibrous roots of Alangium chinense (Lour.) Harms

  2023cites this paper
• Determination of Antiviral Mechanism of Centenarian Gut-Derived Limosilactobacillus fermentum Against Norovirus

  2022cites this paper
• 1,4‐Disubstituted‐1,2,3‐triazole GABA Analogues: Synthesis, In Vitro Evaluation, Quantum QSAR and Molecular Docking against Pseudomonas fluorescens GABA‐AT

  2020cites this paper
• Isolation and characterization of Bioactive Metabolite from Bacillus safensis VRKK2 for controlling Bacterial blight disease in Cowpea.

  2020cites this paper
• Homology modeling of human GABA-AT and devise some novel and potent inhibitors via computer-aided drug design techniques

  2020cites this paper
• ANTHRAQUINONES: A SCAFFOLD HOPE TO NOVEL γ-AMINO BUTYRIC ACID AMINOTRANSFERASE INHIBITORS

  2018cites this paper
• Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.

  2018cites this paper
• Succinate is an inflammatory signal that induces IL-1 beta through HIF-1 alpha

  2017cites this paper
• A New Inhibitor of γ-aminobutric Acid Aminotransferase from Streptomyces sp. ZZ035 Isolated from a Folk Medicinal Soil in China

  2017cites this paper
• Prediction of hydrate and solvate formation using knowledge-based models

  2016cites this paper
• Molecular dynamics simulations of apo, holo, and inactivator bound GABA‐at reveal the role of active site residues in PLP dependent enzymes

  2016cites this paper
• Calix[4]resorcinols modified with γ-aminobutyric acid fragments

  2015cites this paper
• Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1S,3S)-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115)

  2015cites this paper
• Succinate is a danger signal that induces IL-1β via HIF-1α

  2014cites this paper
• Effect of carbon chain length on biological activity of novel palladium (II) complexes.

  2014cites this paper
• Synthesis of carbocyclic and heterocyclic β-aminocarboxylic acids.

  2014cites this paper
• Succinate is an inflammatory signal that induces IL-1β through HIF-1α

  2013cites this paper
• δ-Unsaturated γ-amino acids: enantiodivergent synthesis and cell imaging studies.

  2013cites this paper
• Theoretical study on HF elimination and aromatization mechanisms: a case of pyridoxal 5' phosphate-dependent enzyme.

  2012cites this paper
• A role of GABA analogues in the treatment of neurological diseases.

  2010cites this paper
• Inhibitory role for GABA in autoimmune inflammation

  2010cites this paper
• Synthesis of Carbocyclic -Amino Acids

  2010cites this paper
• Synthesis of γ‐Aminobutyric Acid Analogs

  2010cites this paper
• GABA and Glutamate Receptor Ligands and their Therapeutic Potential in CNS Disorders

  2010cites this paper
• Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins.

  2009cites this paper
• Identifizierung und Charakterisierung der Succinsemialdehyd-Dehydrogenase aus parasitischen und nichtparasitischen Arthropoden

  2009cites this paper
• Regulation of excitation by GABA neurotransmission: focus on metabolism and transport.

  2008cites this paper
• Pyridoxal 5'-phosphate enzymes as targets for therapeutic agents.

  2007cites this paper
• Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors.

  2007cites this paper
• GABA: homeostatic and pharmacological aspects.

  2007cites this paper
• Neuron-Glia Interaction in Homeostasis of the Neurotransmitters Glutamate and GABA

  2007cites this paper
• Pharmacology and Treatments

  2007cites this paper
• Synthesis of Stereoisomers of 3‐Aminocyclohexanecarboxylic Acid and cis‐3‐Aminocyclohexene‐5‐carboxylic Acid

  2006cites this paper
• Glial modulation of GABAergic and glutamat ergic neurotransmission.

  2006cites this paper
• New substrates and inhibitors of gamma-aminobutyric acid aminotransferase containing bioisosteres of the carboxylic acid group: design, synthesis, and biological activity.

  2006cites this paper
• The GABA shunt: an attractive and potential therapeutic target in the treatment of epileptic disorders.

  2005cites this paper
• Conformationally-restricted vigabatrin analogs as irreversible and reversible inhibitors of gamma-aminobutyric acid aminotransferase.

  2004cites this paper
• Pharmacological and Biochemical Aspects of GABAergic Neurotransmission: Pathological and Neuropsychobiological Relationships

  2004cites this paper
• Development of vigabatrin‐induced lesions in the rat brain studied by magnetic resonance imaging, histology, and immunocytochemistry

  2004cites this paper
• Succinate Is a Danger Signal That Induces Il-1β via Hif-1α Nih Public Access

  year unknowncites this paper